MedTrace Logo

Moving Foward With Myeloma (MFM)

NCT07236502 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 184

Last updated 2026-01-12

No results posted yet for this study

Summary

The purpose of this project is to evaluate the impact of a 16-week lifestyle program that promotes changes in eating and exercise patterns. The main questions the study will answer are:

Do improvements in eating and exercise patterns lead to improved physical function, quality of life and blood biomarkers of biologial aging among individuals with multiple myeloma? Participants will complete study activities 3-4 times during the study.

1. In-person assessment to measure physical function, height/weight, body composition, and includes a blood draw
2. Surveys completed online or on paper at home

Conditions

  • Multiple Myeloma (MM)

Interventions

BEHAVIORAL

Immediate intervention

16-session intervention that facilitates changes in nutrition and physical activity behaviors to promote improvements in physical function, Patient Reported Outcomes, body composition and general health

OTHER

Waitlist

Participants will be asked to maintain their behavior over the 16 week waitlist period and will receive weekly text message relating positive messages unrelated to lifestyle

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Loyola University Chicago

    collaborator OTHER

  • Medical College of Wisconsin

    lead OTHER

Principal Investigators

  • Melinda Stolley, PhD · Medical College of Wisconsin

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-01-30
Primary Completion
2029-12-15
Completion
2030-02-28

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07236502 on ClinicalTrials.gov